gdc
Immunotherapy

Choosing Immunotherapy

Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.
Video Library – January 10, 2019
Morganna Freeman, DO, FACP

Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.

Recommended For You
ImmunotherapyMultiple Myeloma
How CAR T-Cell Therapy Gave Cherie Rineker Her Life Back
By Kelsey Moroz
Chemotherapy for multiple myeloma had kept Cherie Rineker alive for 5 years, but then she realized she was slowly dying. So she embarked on a search for a clinical trial and by luck was able to join one. To her amazement, “What 2 stem-cell transplants and 13 other treatments had not been able to do in more than 65 months, CAR T-cell therapy did in less than 1 month,” she said.
Breast CancerFDA Approvals, News & UpdatesImmunotherapy
First Immunotherapy Approved for Patients with Advanced or Metastatic Triple-Negative Breast Cancer Expressing PD-L1
In March 2019, the FDA approved Tecentriq (atezolizumab), a PD-L1 inhibitor, in combination with Abraxane (paclitaxel protein-bound), for use in adults with locally advanced or metastatic triple-negative breast cancer whose tumors cannot be removed by surgery and express PD-L1, as identified by an FDA-approved test. This is the first FDA-approved immunotherapy for patients with advanced or metastatic triple-negative breast cancer.
Cancer ResearchClinical TrialsImmunotherapyPediatric Cancer
Is CAR T-Cell Therapy Safe and Effective?
By Claire White, BSN, RN, CPHON
Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
ImmunotherapyLeukemiaLymphomaPersonalized Medicine
Telling Patients About CAR T-Cell Therapy
By Claire White, BSN, RN, CPHON
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
Last modified: February 27, 2019

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country